Clover Health adds two directors to board of directors

Clover Health Investments, Corp. has appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to the company's board of directors, fulfilling two vacant positions and increasing the board to nine members. Senator Torricelli, who has served on the company's insurance subsidiaries since 2022, will join the audit committee.

Dr. Miller, a practicing hospitalist and associate professor of medicine at Johns Hopkins University, will join the clinical committee. Both new board members bring extensive experience in business, healthcare, and policy-making. Clover Health, a physician enablement technology company, offers Medicare Advantage plans in several states and operates a subsidiary that extends its technology platform to healthcare providers outside its Medicare Advantage plans.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.